Weight loss pills may seem like a quick-fix solution when you want to drop pounds, but they come with significant risks.

Hims & Hers on Saturday announced it would stop offering its copycat of the weight-loss pill Wegovy after threats of legal ...

Demand for GLP-1 drugs continues to climb, boosted by a major price drop and the FDA’s approval of an oral Wegovy pill that has already generated more than 26,000 prescriptions in January.

Feb 12 (Reuters) - Eli Lilly had $1.5 billion worth of pre-launch inventory of its experimental oral weight-loss drug, a ...

By Amina Niasse NEW YORK, Feb 5 (Reuters) - Online telehealth company Hims and Hers Health on Thursday began offering a much cheaper $49 compounded version of Novo Nordisk's new Wegovy weight-loss ...

Blockbuster weight-loss drugs are transforming the way we treat obesity. But while costly injectable versions remain out of ...

How does the new Wegovy pill compare to the shot for weight loss? Here are six ways, from side effects to absorption.

Competition in the race to crack the lucrative weight loss drug market is heating up as rivals like Roche, Eli Lilly, Novo Nordisk and Pfizer develop oral medications that help people shed weight ...

Telehealth company Hims & Hers dropped its plan to offer a knockoff version of the weight-loss pill Wegovy on Saturday — two ...

The company had been seeking new revenue drivers as its original sexual-health business matured, News.Az reports, citing Reuters. But its plan to ...

Hims & Hers said it would stop selling its new compounded semaglutide pill after "constructive conversations with ...